PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+18.66%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$1.3B
AUM Growth
+$1.3B
(+18%)
Cap. Flow
+$50.8M
Cap. Flow
% of AUM
3.91%
Top 10 Holdings %
Top 10 Hldgs %
53.38%
Holding
188
New
39
Increased
28
Reduced
33
Closed
30
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$45.3M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$21.1M |
| 3 |
Baxter International
BAX
|
$16.2M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$13.8M |
| 5 |
CytomX Therapeutics
CTMX
|
$13.4M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$25.3M |
| 2 |
Sarepta Therapeutics
SRPT
|
$21M |
| 3 |
RLYP
RELYPSA INC COM
RLYP
|
$18.3M |
| 4 |
CEMP
Cempra, Inc.
CEMP
|
$16.2M |
| 5 |
SHPG
Shire pic
SHPG
|
$8.42M |
Sector Composition
| 1 | Healthcare | 89.63% |
| 2 | Consumer Discretionary | 0.08% |
| 3 | Financials | 0.04% |
| 4 | Consumer Staples | 0.02% |
| 5 | Energy | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amicus Therapeutics
FOLD
$2.34B
| $148M | 10.94% | 15,239,444 +800,000 | +6% | +$7.76M |
|
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $141M | 10.45% | 2,496,167 -446,800 | -15% | -$25.3M |
|
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $86.5M | 6.4% | 2,240,928 -544,000 | -20% | -$21M |
|
|
DYAX
4
DELISTED
DYAX CORPORATION
DYAX
| $68.4M | 5.06% | 1,819,215 +172,900 | +11% | +$6.5M |
|
|
TSRO
5
DELISTED
TESARO, Inc.
TSRO
| $50.7M | 3.75% | 968,659 -13,100 | -1% | -$685K |
|
6
Travere Therapeutics
TVTX
$1.56B
| $49.8M | 3.68% | 2,579,380 -67,700 | -3% | -$1.31M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $45.3M | 3.35% | +145,000 | New | +$45.3M |
|
|
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $38.4M | 2.84% | 1,186,630 +264,830 | +29% | +$8.56M |
|
|
NVRO
9
DELISTED
NEVRO CORP.
NVRO
| $32.7M | 2.42% | 484,279 -122,532 | -20% | -$8.27M |
|
|
10
Teva Pharmaceuticals
TEVA
$21.1B
| $31.6M | 2.34% | 481,000 +321,000 | +201% | +$21.1M |
|
|
ARAV
11
DELISTED
Aravive, Inc. Common Stock
ARAV
| $28.5M | 2.11% | 2,299,454 -18,500 | -0.8% | -$229K |
|
12
Xencor
XNCR
$580M
| $27.1M | 2.01% | 1,854,784 +100,000 | +6% | +$1.46M |
|
|
RXDX
13
DELISTED
Ignyta, Inc.
RXDX
| $24.3M | 1.8% | 1,812,060 -119,540 | -6% | -$1.6M |
|
14
Iovance Biotherapeutics
IOVA
$807M
| $23.2M | 1.71% | 3,000,161 +44,705 | +2% | +$345K |
|
15
Talphera
TLPH
$11.1M
| $23.1M | 1.71% | 5,995,760 -268,300 | -4% | -$1.03M |
|
|
16
Baxter International
BAX
$12.7B
| $18.5M | 1.37% | 485,000 +425,000 | +708% | +$16.2M |
|
|
FPRX
17
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $18M | 1.33% | 434,129 +150,000 | +53% | +$6.22M |
|
|
AGTC
18
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $17.6M | 1.3% | 861,513 +10,521 | +1% | +$215K |
|
|
LJPC
19
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $17.5M | 1.3% | 649,515 -5,000 | -0.8% | -$135K |
|
|
DERM
20
DELISTED
Dermira, Inc.
DERM
| $17.4M | 1.29% | 502,000 +30,000 | +6% | +$1.04M |
|
21
uniQure
QURE
$896M
| $16M | 1.18% | 967,093 +276,824 | +40% | +$4.58M |
|
|
QTNT
22
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $14.3M | 1.06% | 893,540 +116,737 | +15% | +$1.87M |
|
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $13.8M | 1.02% | +110,000 | New | +$13.8M |
|
|
XLRN
24
DELISTED
Acceleron Pharma Inc.
XLRN
| $13.5M | 1% | 276,036 | – | – |
|
|
25
CytomX Therapeutics
CTMX
$336M
| $13.4M | 0.99% | +642,047 | New | +$13.4M |
|